Lab Automation And Personalized Medicine Will Unlock Secular Opportunities
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 9 Analysts
Published
18 Jul 25
Updated
15 Aug 25
AnalystHighTarget's Fair Value
CHF 351.30
51.4% undervalued intrinsic discount15 Aug
CHF 170.60
1Y
-40.1%7D
9.5%